局部氨酸对口腔平的影响 进化:随机对照临床试验
Alessandro Polizzi1, Gianluca Martino Tartaglia2,3, Simona Santonocito1
1Department of General Surgery and Surgical-Medical Specialties, School of Dentistry, University of Catania, Catania, Italy.
Oral diseases
|October 15, 2024
概括
与安慰剂相比,在六个月内,局部使用的0.05%流胺凝有效地减少了口腔平坦 (OLP) 的症状和迹象. 焦虑和抑郁等心理因素也影响了OLP的结果和治疗反应.
科学领域:
- 皮肤病学 皮肤病学
- 口腔医学是指口腔医学.
- 临床药理学 临床药理学
背景情况:
- 口腔平坦 (OLP) 是一种慢性炎症状况,影响口腔粘膜.
- 局部皮质类固醇是一种常见的治疗方法,但疗效不同.
- 酸凝为OLP管理提供了一种新的配方.
研究的目的:
- 为了评估素化物0.05%凝在治疗口腔平坦的疗效.
- 评估素对OLP症状,征兆和疾病严重程度的影响.
- 探索心理因素在OLP结果和治疗反应中的作用.
主要方法:
- 采用了一种随机对照试验 (RCT) 设计.
- 47名患有OLP的患者被随机分配,接受0.05%的氨酸凝或安慰剂.
- 包括OLP症状,征兆和延长得分在内的结果在6个月的随访期间进行了监测.
主要成果:
- 与安慰剂相比,在6个月后,0.05%的氨酸凝显著降低了OLP症状,征兆和延长得分,与安慰剂相比 (p < 0.05).
- 统计分析证实了氨酸对OLP结果的积极和显著影响.
- 多变量分析确定焦虑,压力和抑郁症是OLP结果的重要预测因素.
结论:
- 局部注射的0.05%氨酸凝在治疗口服状平原菌方面表现出比安慰剂更好的疗效.
- 焦虑,抑郁和压力等心理因素显著影响OLP,并可能增强氨酸的治疗益处.
相关概念视频
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
2.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.3K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
692
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
692
Acne Infection
94
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
94


